Clinical Trial

HeartLogic™ in Patients With Heart Failure.

Study acronym: HERO
Recruiting
View on ClinicalTrials.gov →
Summary
This randomized, multicenter clinical trial will evaluate whether remote management guided by the HeartLogic™ algorithm improves outcomes compared with traditional face-to-face follow-up in adult patients with heart failure recently implanted with a HeartLogic™-enabled ICD or CRT-D device. The primary objective is to determine whether this strategy reduces, at 12 months, the proportion of patients with death, unscheduled hospitalization for heart failure, or deterioration in quality of life. Secondary objectives include assessment of hospitalization, mortality, quality of life, safety, and cost-effectiveness.
Protocol Amendment History 1 change
critical Recruitment opened 2026-06-25
Trial Details
NCT Number NCT07544771
Lead Sponsor Poitiers University Hospital
Conditions Heart Failure
Enrollment 578 participants
Start Date 2026-04-29
Primary Completion 2028-10-15 (estimated)
Study Completion 2029-05-15 (estimated)
Updated on ClinicalTrials.gov 2026-06-24